Suppr超能文献

静脉穿刺点消毒帽在降低 COVID-19 期间中心静脉导管相关血流感染、临床应用及护理成本方面的有效性

Effectiveness of Disinfecting Caps for Intravenous Access Points in Reducing Central Line-Associated Bloodstream Infections, Clinical Utilization, and Cost of Care During COVID-19.

作者信息

Hou Yuefeng, Griffin Leah P, Ertmer Kari, Bernatchez Stéphanie F, Kärpänen Tarja J, Palka-Santini Maria

机构信息

3M Health Care, 3M Company, Austin, TX, USA.

3M Health Care, 3M Company, San Antonio, TX, USA.

出版信息

Clinicoecon Outcomes Res. 2023 Jun 21;15:477-486. doi: 10.2147/CEOR.S404823. eCollection 2023.

Abstract

PURPOSE

Intravenous (IV) access point protectors, serving as passive disinfection devices and a cover between line accesses, are available to help reduce the risk of central line-associated bloodstream infections (CLABSIs). This low-maintenance disinfection solution is particularly valuable in situations with excessive workloads. This study examined the effect of a disinfecting cap for an IV access point on CLABSI rates, hospital length of stay, and cost of care in an inpatient setting during the coronavirus disease 2019 (COVID-19) pandemic.

METHODS

The study utilized data from the Premier Healthcare Database, focusing on 200,411 hospitalizations involving central venous catheters between January 2020 and September 2020. Among these cases, 7423 patients received a disinfecting cap, while 192,988 patients did not use any disinfecting caps and followed the standard practice of hub scrubbing. The two cohorts, Disinfecting Cap and No-Disinfecting Cap groups, were compared in terms of CLABSI rates, hospital length of stay (LOS), and hospitalization costs. The analysis accounted for baseline group differences and random clustering effects by employing a 34-variable propensity score and mixed-effect multiple regression, respectively.

RESULTS

The findings demonstrated a significant 73% decrease in CLABSI rates (p= 0.0013) in the Disinfecting Cap group, with an adjusted CLABSI rate of 0.3% compared to 1.1% in the No-Disinfecting Cap group. Additionally, the Disinfecting Cap group exhibited a 0.5-day reduction in hospital stay (9.2 days versus 9.7 days; p = 0.0169) and cost savings of $6703 ($35,604 versus $42,307; p = 0.0063) per hospital stay compared to the No-Disinfecting Cap group.

CONCLUSION

This study provides real-world evidence that implementing a disinfecting cap to protect IV access points effectively reduces the risk of CLABSIs in hospitalized patients compared to standard care, ultimately optimizing the utilization of healthcare resources, particularly in situations where the healthcare system is under significant strain or overloaded.

摘要

目的

静脉输液接入点保护器作为被动消毒装置和线路接入之间的覆盖物,有助于降低中心静脉导管相关血流感染(CLABSI)的风险。这种低维护消毒解决方案在工作量过大的情况下尤其有价值。本研究考察了一种静脉输液接入点消毒帽对2019冠状病毒病(COVID-19)大流行期间住院患者CLABSI发生率、住院时间和护理成本的影响。

方法

该研究利用了Premier医疗数据库的数据,重点关注2020年1月至2020年9月期间涉及中心静脉导管的200411例住院病例。在这些病例中,7423例患者使用了消毒帽,而192988例患者未使用任何消毒帽,遵循了标准的接头擦拭做法。对消毒帽组和未使用消毒帽组这两个队列在CLABSI发生率、住院时间(LOS)和住院费用方面进行了比较。分析分别采用34变量倾向得分和混合效应多元回归来考虑基线组差异和随机聚类效应。

结果

研究结果表明,消毒帽组的CLABSI发生率显著降低了73%(p = 0.0013),调整后的CLABSI发生率为0.3%,而未使用消毒帽组为1.1%。此外,与未使用消毒帽组相比,消毒帽组的住院时间缩短了0.5天(9.2天对9.7天;p = 0.0169),每次住院节省成本6703美元(35604美元对42307美元;p = 0.0063)。

结论

本研究提供了实际证据,表明与标准护理相比,使用消毒帽保护静脉输液接入点可有效降低住院患者发生CLABSI的风险,最终优化医疗资源的利用,特别是在医疗系统面临重大压力或过载的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d91/10290837/538283678031/CEOR-15-477-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验